Overview
Xiaowen Tang practices in Nanjing, China. Tang is rated as an Experienced expert by MediFind in the treatment of Disseminated Intravascular Coagulation. Their top areas of expertise are Leukemia, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Aplastic Anemia, and Bone Marrow Transplant.
Their clinical research consists of co-authoring 143 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Disseminated Intravascular Coagulation.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bone Marrow TransplantTang isDistinguished. Learn about Bone Marrow Transplant.
- LeukemiaTang isDistinguished. Learn about Leukemia.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Adult T-Cell LeukemiaTang isAdvanced. Learn about Adult T-Cell Leukemia.
- AnemiaTang isAdvanced. Learn about Anemia.
- Aplastic AnemiaTang isAdvanced. Learn about Aplastic Anemia.
- Graft Versus Host Disease (GvHD)
- Experienced
- Acute Promyelocytic Leukemia
- Bile Duct ObstructionTang isExperienced. Learn about Bile Duct Obstruction.
- Breast CancerTang isExperienced. Learn about Breast Cancer.
- CholestasisTang isExperienced. Learn about Cholestasis.
- Chronic Graft Versus Host Disease (cGvHD)
- Chronic Myelogenous Leukemia (CML)